How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Direct Primary Care Market
- By Service Model: Membership-Based Model, Capitation Model, Hybrid Model, Fee-for-Service Model
- By Patient Demographics: Pediatric Care, Adult Care, Geriatric Care, Chronic Disease Management
- By Provider Type: Independent Physicians, Physician Groups, Nurse Practitioners, Physician Assistants
- By Care Delivery Channel: In-Clinic Visits, Telemedicine Services, Home Visits, Mobile Health Units
- By Payment Structure: Monthly Subscription, Annual Subscription, Family Plans, Employer-Sponsored Plans
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Membership-Based Model leads By Service Model at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Direct Primary Care Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →One Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Forward Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Iora Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Qliance
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Atlas.md
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Paladina Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →MDVIP
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Crossover Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Vimly Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Parsley Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Circle Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Membership-Based Model40.7
- Capitation Model25.2
- Hybrid Model19.2
- Fee-for-Service Model14.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- One Medical17.6
- Forward Health9.9
- Iora Health13.1
- Qliance7.8
- Atlas.md12.2
- Paladina Health11.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe24.8
- Asia Pacific20.3
- Latin America12.9
- Middle East and Africa9.7
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| One Medical | 92 | 74 | 74 | 74 | 78 | 86 | 80 |
| Forward Health | 93 | 71 | 77 | 85 | 74 | 83 | 81 |
| Iora Health | 80 | 85 | 66 | 71 | 73 | 72 | 75 |
| Qliance | 80 | 72 | 72 | 75 | 58 | 58 | 69 |
| Atlas.md | 54 | 59 | 67 | 77 | 55 | 76 | 65 |
| Paladina Health | 69 | 51 | 54 | 53 | 52 | 60 | 57 |
| MDVIP | 40 | 49 | 42 | 43 | 41 | 66 | 47 |
| Crossover Health | 44 | 53 | 36 | 40 | 60 | 38 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- One Medical
- Forward Health
- Iora Health
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| One Medical | ✓ | ✓ | − | − | ◐ | ◐ |
| Forward Health | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Iora Health | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Qliance | ✓ | − | − | ◐ | ◐ | ◐ |
| Atlas.md | − | − | ◐ | ◐ | ◐ | ✓ |
| Paladina Health | ◐ | − | ◐ | − | ◐ | − |
| MDVIP | − | − | − | − | ◐ | ◐ |
| Crossover Health | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Service Model in North America, then scale across Direct Primary Care Market — a $683M beachhead inside a $9.60B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Membership-Based Model
Best fit — highest urgency & budget in Service Model.
Capitation Model
Strong fit — clear ROI and a fast path to value.
Hybrid Model
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Model in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Patient Demographics & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Provider Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Service Model leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Direct Primary Care Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Direct Primary Care Market is a durable-growth opportunity — $4.53B by 2033, compounding at 6.2%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.2% CAGR
Demand compounds through 2033, outpacing GDP across Service Model.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Model moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Patient Demographics optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Direct Primary Care Market — a $1.90B market by 2033. Plan: grow share from 10.8% to 16.8%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.8% | 16.8% | Ahead |
| Revenue | $204M | $320M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 30.8% | 45.6% | On track |
| Customer retention | 90.4% | 94.7% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Service Model
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Patient Demographics capability
A defensible second engine — invest in Patient Demographics to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Model share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Patient Demographics
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $35M capacity & capability investment
- Greenlight bolt-on M&A in Patient Demographics
- Authorise North America expansion plan
- Fund R&D program for Service Model leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Sales deck · value proposition
Win the Direct Primary Care Market conversation — a $924M market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Model
Goal Grow share in Service Model
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Direct Primary Care Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Direct Primary Care Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Sleeve Rubber Stopper Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportL-Arginine HCL Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportMedical Rigid Foam Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportMedical Processing Seal Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportLife Sciences & Analytical Reagents Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVanadyl Acetylacetonate Market
Market size, share, segmentation and regional forecast.
$678M market · 2025 base year
View reportUltrasound Conductive Gels Market
Market size, share, segmentation and regional forecast.
$652M market · 2025 base year
View reportDirectional X-ray Generator Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportIdebenone Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportHollow Silica Market
Market size, share, segmentation and regional forecast.
$490M market · 2025 base year
View reportDirect Imaging Particle Analyzer Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportDirect Heating CO2 Incubator Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy